✦ LIBER ✦

Chemotherapy versus chemotherapy plus radiotherapy for stage IIIA, IIIB Hodgkin's disease. A southwest oncology group study

✍ Scribed by E.J. De Persio; P.N. Grozea; R. Fisher; S.E. Jones; C.A. Coltman

Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 84 KB
Volume: 5
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(79)90447-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized study of radiotherapy versu

A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-hodgkin's lymphomas

✍ Nis I. Nissen; Jens Ersbøll; Hanne Sand Hansen; Sven Walbom-Jørgensen; Jens Pede 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

In a randomized, prospective trial from 1974-1978, 73 patients with non-Hodgkin's lymphomas in clinical Stage I or II were treated with extended field radiotherapy alone (RT) or RT plus adjuvant chemotherapy with vincristine, streptonigrin, cyclophosphamide and prednisone (RT + CT). With a median fo

Comparison of adriamycin-containing chem

Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-bleomycin in the management of advanced Hodgkin-s disease a southwest oncology group study

✍ Stephen E. Jones; Arthur Haut; James K. Weick; Henry E. Wilson; Petre Grozea; Ca 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 759 KB

Sequential non-cross-resistant chemother

Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IV

✍ D. J. Theo Wagener; J. Marion V. Burgers; Ad W. Dekker; Ismail Kazem; H. A. Van 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB 👁 1 views

Long term follow-up of combination chemo

Long term follow-up of combination chemotherapy-radiotherapy of stage III Hodgkin's disease. A cancer and acute leukemia group B study

✍ Barth Hoogstraten; Oliver Glidewell; James F. Holland; Johannes Blom; Leon Stutz 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 772 KB

Combination chemotherapy (CMFVP) versus

Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes. A southwest oncology group study

✍ Harold Glucksberg; Saul E. Rivkin; Shelley Rasmussen; Bill Tranum; Nazli Gad-el- 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 970 KB

The Southwest Oncology Group in a prospective randomized study compared one year of adjuvant combination chemotherapy with continuous CMFVP to two years of intermittent L-PAM in women with operable breast cancer with histologically positive axillary lymph nodes. In fully evaluable patients with a 42